NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/24/2026
Back to search
Official data from USPTO
WORLDWIDE EVIDENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WORLDWIDE EVIDENCE
ST13
US500000087689214Class
35, 41, 42
Filing
87689214
Registration
5777758
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/25/2026
Trademark type
Word
Nice classes
35, 41, 42
Filing date
11/17/2017
Registration date
06/11/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/30/2018
First use in commerce
06/30/2018
Drawing code
4
Owner type
03
Owner location
Durham, NC, US
Examiner
LORENZO, KATHLEEN H
Current location
Historical data usage
Holders and representatives
Holders
Worldwide Clinical Trials, Inc.
Worldwide Clinical Trials, Inc.
Representatives
Lindsay Lehrer Worldwide Clinical Trials, Inc.
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trials; Pharmaceutical cost management services and drug utilization review services; Business management assistance and consultation for clinical trials of observational research designsmanagement and compilation of information in the field of clinical trials for business purposessurveysretrospective chart reviewprospective longitudinal cohort studiespost approval safety studies (pass)registriesinterventional studies for approved and investigational drugs; Business management servicesarranging for sites to perform clinical trialsarranging for the importpackagingshipping labelingdistribution of drugs and other investigational supplies to and from the clinical trial sites as appropriate to the study designarranging for the central collection of laboratory specimens from clinical trial sitesextracting data from clinical trial records including electronic healthcare recordsmaking any and all filings required by the food and drug administration as well as the EMA for observational researchas appropriate investigational new drugspreparing statistical reports resulting from clinical trials an studiesall for business purposes
Class 41
Training clinical trial site personnel concerning protocol requirements and the use of tests and rating systems for such protocol; training clinical trial site personnel in the use of medical and research equipment and procedures required by protocols
Class 42
Pharmaceutical research services; Pharmaceutical research and development; Technical writing of clinical report forms for others which are required by clinical trial study protocols; Technical writing of clinical trial reports for others; Database development services to process data collected from clinical trials
Publications
History of USPTO decisions and trademark events.
33 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/24/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/23/2026
ES8R
TEAS SECTION 8 RECEIVED
11/04/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/11/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/20/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/01/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/11/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/03/2019
ALIE
ASSIGNED TO LIE
04/29/2019
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/19/2019
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/18/2019
IUAA
USE AMENDMENT ACCEPTED
04/18/2019
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/16/2019
IUAF
USE AMENDMENT FILED
04/16/2019
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/15/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/11/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/15/2018
GNFR
FINAL REFUSAL E-MAILED
10/15/2018
CNFR
FINAL REFUSAL WRITTEN
10/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/12/2018
GNRT
NON-FINAL ACTION E-MAILED
03/12/2018
CNRT
NON-FINAL ACTION WRITTEN
03/12/2018
DOCK
ASSIGNED TO EXAMINER
03/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2017
NWAP
NEW APPLICATION ENTERED
11/21/2017
Continuous trademark protection
Get notified about every new filing that threatens WORLDWIDE EVIDENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.